A szerzők célja, hogy a fellelhető szakirodalom alapján áttekintést adjanak a korai stádiumú petefészek-daganatok, azon belül is elsősorban a hámeredetű daganatok termékenységet megőrző kezelési lehetőségeiről, illetve azok onkológiai és szülészeti kimeneteléről. Korai stádiumú borderline, csírasejtes, valamint ivarléc-stroma sejtes petefészek-daganatok esetén régóta elfogadott, epithelialis ovariumcarcinoma esetén azonban csak néhány éve alkalmazott a termékenységet megőrző kezelés. Fertilitást megtartó sebészeti kezelés IA stádiumú, grade 1–2, kedvező szövettani altípusú ovariumcarcinoma esetén javasolható. IA stádium felett, illetve grade 3 vagy világos sejtes carcinoma esetén konzerváló műtét csak egyéni mérlegelés alapján ajánlható. Minden esetben javasolt a standard műtétnek megfelelő sebészeti stádiummeghatározást elvégezni. Fertilitást megőrző kezelés alkalmazása nem veszélyeztetheti az onkológiai kezelés hatékonyságát. Kellő körültekintéssel végezve, a fertilitást megtartó kezelések onkológiai megbízhatósága megegyezik a radikális műtétekével. A spontán teherbe esési ráta változó, de átlagosan kedvezőnek mondható. Kiemelten fontos a megfelelő betegtájékoztatás. Fertilitást megtartó műtétet követően gyakori kontrollvizsgálatok szükségesek. A betegek korszerű ellátása centrumokban biztosítható. Orv. Hetil., 2013, 154, 523–530.
Morice, P., Denschlag, D., Rodolakis, A., et al., Fertility Task Force of the European Society of Gynecologic Oncology: Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int. J. Gynecol. Cancer, 2011, 21, 951–963.
Rodolakis A. , 'Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors ' (2011 ) 21 Int. J. Gynecol. Cancer : 951 -963 .
Ayhan, A., Celik, H., Taskiran, C., et al.: Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur. J. Gynaecol. Oncol., 2003, 24, 223–232.
Taskiran C. , 'Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer ' (2003 ) 24 Eur. J. Gynaecol. Oncol. : 223 -232 .
Fotopoulou, C., Braicu, I., Sehouli, J.: Fertility-sparing surgery in early epithelial ovarian cancer: a viable option? Obstet. Gynecol. Int., 2012, 2012, 238061.
Sehouli J. , 'Fertility-sparing surgery in early epithelial ovarian cancer: a viable option? ' (2012 ) 2012 Obstet. Gynecol. Int. : 238061 -.
Lee, S. J., Schover, L. R., Partridge, A. H., et al.: American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J. Clin. Oncol., 2006, 24, 2917–2931.
Partridge A. H. , 'American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients ' (2006 ) 24 J. Clin. Oncol. : 2917 -2931 .
Colombo, N., Peiretti, M., Parma, G., et al., ESMO Guidelines Working Group: Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2010, 21 (Suppl. 5), v23–v30.
Parma G. , 'Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ' (2010 ) 21 Ann. Oncol. : v23 -v30 .
Morice, P., Leblanc, E., Rey, A., et al., GCCLCC and SFOG: Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Française d’Oncologie Gynécologique). Hum. Reprod., 2005, 20, 1379–1385.
Rey A. , 'Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Française d’Oncologie Gynécologique) ' (2005 ) 20 Hum. Reprod. : 1379 -1385 .
Satoh, T., Hatae, M., Watanabe, Y., et al.: Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J. Clin. Oncol., 2010, 28, 1727–1732.
Watanabe Y. , 'Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection ' (2010 ) 28 J. Clin. Oncol. : 1727 -1732 .
Schilder, J. M., Thompson, A. M., DePriest, P. D., et al.: Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol. Oncol., 2002, 87, 1–7.
DePriest P. D. , 'Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy ' (2002 ) 87 Gynecol. Oncol. : 1 -7 .
Zanetta, G., Chiari, S., Rota, S., et al.: Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br. J. Obstet. Gynaecol., 1997, 104, 1030–1035.
Rota S. , 'Conservative surgery for stage I ovarian carcinoma in women of childbearing age ' (1997 ) 104 Br. J. Obstet. Gynaecol. : 1030 -1035 .
Chan, J. K., Urban, R., Cheung, M. K., et al.: Ovarian cancer in younger vs older women: a population based analysis. Br. J. Cancer, 2006, 95, 1314–1320.
Cheung M. K. , 'Ovarian cancer in younger vs older women: a population based analysis ' (2006 ) 95 Br. J. Cancer : 1314 -1320 .
Nemzeti Rákregiszter, 2010-ben felfedezett és bejelentett új rosszindulatú daganatok (nők, országos összesítés, korcsoport szerint) http://www.oncol.hu/rakreg/stat/ [Hungarian]
Ferrero, A., Strada, I., Di Marcoberardino, B., et al.: Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management. Int. J. Gynecol. Cancer, 2012, 22, 1158–1162.
Marcoberardino B. , 'Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management ' (2012 ) 22 Int. J. Gynecol. Cancer : 1158 -1162 .
Nam, J. H.: Borderline ovarian tumors and fertility. Curr. Opin. Obstet. Gynecol., 2010, 22, 227–234.
Nam J. H. , 'Borderline ovarian tumors and fertility ' (2010 ) 22 Curr. Opin. Obstet. Gynecol. : 227 -234 .
Song, T., Choi, C. H., Kim, H. J., et al.: Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors. Eur. J. Obstet. Gynecol. Reprod. Biol., 2011, 156, 204–208.
Kim H. J. , 'Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors ' (2011 ) 156 Eur. J. Obstet. Gynecol. Reprod. Biol. : 204 -208 .
National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology, Ovarian Cancer http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
De Iaco, P., Ferrero, A., Rosati, F., et al.: Behaviour of ovarian tumors of low malignant potential treated with conservative surgery. Eur. J. Surg. Oncol., 2009, 35, 643–648.
Rosati F. , 'Behaviour of ovarian tumors of low malignant potential treated with conservative surgery ' (2009 ) 35 Eur. J. Surg. Oncol. : 643 -648 .
Morice, P., Camatte, S., El Hassan, J., et al.: Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil. Steril., 2001, 75, 92–96.
Hassan J. , 'Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors ' (2001 ) 75 Fertil. Steril. : 92 -96 .
Yinon, Y., Beiner, M. E., Gotlieb, W. H., et al.: Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil. Steril., 2007, 88, 479–484.
Gotlieb W. H. , 'Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors ' (2007 ) 88 Fertil. Steril. : 479 -484 .
Park, J. Y., Kim, D. Y., Kim, J. H., et al.: Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery. Gynecol. Oncol., 2009, 113, 75–82.
Kim J. H. , 'Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery ' (2009 ) 113 Gynecol. Oncol. : 75 -82 .
Park, J. Y., Kim, D. Y., Suh, D. S., et al.: Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol. Oncol., 2008, 110, 345–353.
Suh D. S. , 'Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes ' (2008 ) 110 Gynecol. Oncol. : 345 -353 .
Colombo, N., Parma, G., Lapresa, M. T., et al.: Role of conservative surgery in ovarian cancer: the European experience. Int. J. Gynecol. Cancer, 2005, 15 (Suppl. 3), 206–211.
Lapresa M. T. , 'Role of conservative surgery in ovarian cancer: the European experience ' (2005 ) 15 Int. J. Gynecol. Cancer : 206 -211 .
Kajiyama, H., Shibata, K., Mizuno, M., et al.: Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br. J. Cancer, 2011, 105, 1288–1294.
Mizuno M. , 'Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery ' (2011 ) 105 Br. J. Cancer : 1288 -1294 .
Wright, J. D., Shah, M., Mathew, L., et al.: Fertility preservation in young women with epithelial ovarian cancer. Cancer, 2009, 115, 4118–4126.
Mathew L. , 'Fertility preservation in young women with epithelial ovarian cancer ' (2009 ) 115 Cancer : 4118 -4126 .
Schlaerth, A. C., Chi, D. S., Poynor, E. A., et al.: Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int. J. Gynecol. Cancer, 2009, 19, 1199–1204.
Poynor E. A. , 'Long-term survival after fertility-sparing surgery for epithelial ovarian cancer ' (2009 ) 19 Int. J. Gynecol. Cancer : 1199 -1204 .
Marpeau, O., Schilder, J., Zafrani, Y., et al.: Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer. Ann. Surg. Oncol., 2008, 15, 478–483.
Zafrani Y. , 'Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer ' (2008 ) 15 Ann. Surg. Oncol. : 478 -483 .
Simpkins, F., Abu Shahim, F., Bakkum-Gamez, J. N., et al.: Recurrence in ovarian carcinoma stage I A/B grade 1 and 2 with and without chemotherapy. J. Clin. Oncol. (Meeting abstracts), 2007, 25 (18 Suppl.), 5565.
Bakkum-Gamez J. N. , 'Recurrence in ovarian carcinoma stage I A/B grade 1 and 2 with and without chemotherapy ' (2007 ) 25 J. Clin. Oncol. (Meeting abstracts) : 5565 -.
Trimbos, J. B., Parmar, M., Vergote, I., et al.: International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J. Natl. Cancer Inst., 2003, 95, 105–112.
Vergote I. , 'International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma ' (2003 ) 95 J. Natl. Cancer Inst. : 105 -112 .
Matthews, M. L., Hurst, B. S., Marshburn, P. B., et al.: Cancer, fertility preservation, and future pregnancy: a comprehensive review. Obstet. Gynecol. Int., 2012, 2012, 953937.
Marshburn P. B. , 'Cancer, fertility preservation, and future pregnancy: a comprehensive review ' (2012 ) 2012 Obstet. Gynecol. Int. : 953937 -.
Bedaiwy, M. A., Abou-Setta, A. M., Desai, N., et al.: Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil. Steril., 2011, 95, 906–914.
Desai N. , 'Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis ' (2011 ) 95 Fertil. Steril. : 906 -914 .
Dittrich, R., Lotz, L., Keck, G., et al.: Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil. Steril., 2012, 97, 387–390.
Keck G. , 'Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation ' (2012 ) 97 Fertil. Steril. : 387 -390 .
Grynberg, M., Poulain, M., Sebag-Peyrelevade, S., et al.: Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil. Steril., 2012, 97, 1260–1268.
Sebag-Peyrelevade S. , 'Ovarian tissue and follicle transplantation as an option for fertility preservation ' (2012 ) 97 Fertil. Steril. : 1260 -1268 .
Kolp, L. A., Hubayter, Z.: Autotransplantation of cryopreserved ovarian tissue: a procedure with promise, risks, and a need for a registry. Fertil. Steril., 2011, 95, 1879–1886.
Hubayter Z. , 'Autotransplantation of cryopreserved ovarian tissue: a procedure with promise, risks, and a need for a registry ' (2011 ) 95 Fertil. Steril. : 1879 -1886 .
Müller, A., Keller, K., Wacker, J., et al.: Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany. Dtsch. Arztebl. Int., 2012, 109, 8–13.
Wacker J. , 'Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany ' (2012 ) 109 Dtsch. Arztebl. Int. : 8 -13 .
Von Wolff, M., Donnez, J., Hovatta, O., et al.: Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy – a technique in its infancy but already successful in fertility preservation. Eur. J. Cancer, 2009, 45, 1547–1553.
Hovatta O. , 'Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy – a technique in its infancy but already successful in fertility preservation ' (2009 ) 45 Eur. J. Cancer : 1547 -1553 .
Lawrenz, B., Jauckus, J., Kupka, M. S., et al.: Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch. Gynecol. Obstet., 2011, 283, 651–656.
Kupka M. S. , 'Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques ' (2011 ) 283 Arch. Gynecol. Obstet. : 651 -656 .
Von Wolff, M., Dian, D.: Fertility preservation in women with malignant tumors and gonadotoxic treatments. Dtsch. Arztebl. Int., 2012, 109, 220–226.
Dian D. , 'Fertility preservation in women with malignant tumors and gonadotoxic treatments ' (2012 ) 109 Dtsch. Arztebl. Int. : 220 -226 .
Kesic, V., Rodolakis, A., Denschlag, D., et al.: Fertility preserving management in gynecologic cancer patients: the need for centralization. Int. J. Gynecol. Cancer, 2010, 20, 1613–1619.
Denschlag D. , 'Fertility preserving management in gynecologic cancer patients: the need for centralization ' (2010 ) 20 Int. J. Gynecol. Cancer : 1613 -1619 .